SCHEMBL23588100

SCHEMBL23588100

CCCCOc1ccc(Cc2noc(CC(C(=O)OC(C)(C)C)P(=O)(OCC)OCC)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
PSMB5 P28074 1/20 0.35
PLA2G2A P14555 1/20 0.35
SMPD1 P17405 1/20 0.35
S1PR4 O95977 3/20 0.35
S1PR1 P21453 3/20 0.35
S1PR3 Q99500 3/20 0.35
S1PR5 Q9H228 3/20 0.35
F2 P00734 1/20 0.34
PLG P00747 1/20 0.34
KLKB1 P03952 1/20 0.34
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
TPSAB1 Q15661 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
PDE4A P27815 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25801911 0.92 MAPT (0.37) MAPTPSMB5PLA2G2ASMPD1S1PR4
SCHEMBL23578163 0.91 MEN1 (0.33) LMNASRCZAP70
SCHEMBL25804866 0.90 SRC (0.34) S1PR4S1PR1S1PR3S1PR5SRC
SCHEMBL25805969 0.89 MEN1 (0.33) MAPTPSMB5KDM4ESMN1; SMN2HDAC6
SCHEMBL23578554 0.88 EPHX2 (0.40) MAPTLMNASRCZAP70
SCHEMBL23578356 0.87 MEN1 (0.33) MAPTPSMB5LMNASRCZAP70
SCHEMBL25804329 0.87 MAPT (0.41) MAPTSMPD1KDM4ELMNASRC
SCHEMBL23588157 0.87 MAPT (0.41) MAPTSMPD1KDM4ELMNASRC
SCHEMBL25804590 0.87 KMT2A (0.35) MAPTCYP1A2SMN1; SMN2HDAC6LMNA
SCHEMBL23578227 0.87 ZAP70 (0.36) MAPTPSMB5LMNASRCZAP70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2023-07-13 US disclosed
EP-4081511-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES Sitryx Therapeutics Limited (GB) 2022-11-02 EP disclosed
CN-115066418-A Carboxy derivatives with anti-inflammatory properties 西特瑞治疗有限公司 2022-09-16 CN disclosed
WO-2021130492-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES CPA2, RO60, C5AR1 MAPT 4683/4885PSMB5 1688/4885PLA2G2A 1635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.